Biotage Ab Profile

Performance

Odds of Distress

Analyze Filter    Check how we calculate scores
Equity ratings for Biotage Ab Ord A are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 14, 2019 and ending today December 13, 2019. Click here to learn more.
Biotage Ab Ord A cannot be verified against its exchange. It appears that Biotage Ab is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Biotage Ab Profile

Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage Ab is traded on BATS Exchange in USA.. The public information regarding Biotage Ab Ord A's current market price is not available at this time.
NameBiotage Ab Ord A
President and CEOTorben JoergensenView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business AddressBox 8
ExchangeBATS Exchange
BenchmarkDOW
Websitewww.biotage.com
Phone46 18 56 59 00
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Biotage Ab Ord A [BITGF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with current market capitalization of 807.35 M. Biotage Ab Ord has 64.71 M outstanding shares. BIOTAGE AB has accumulated about 15.1 M in cash with 19.09 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Biotage Ab Probability Of Bankruptcy

Biotage Ab Key Fundamentals

Biotage Ab Against Markets

Biotage Ab Ord A cannot be verified against its exchange. It appears that Biotage Ab is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage Ab is traded on BATS Exchange in USA.. The public information regarding Biotage Ab Ord A's current market price is not available at this time.
NameBiotage Ab Ord A
President and CEOTorben JoergensenView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business AddressBox 8
ExchangeBATS Exchange
BenchmarkDOW
Websitewww.biotage.com
Phone46 18 56 59 00
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018

Biotage Ab Corporate Directors

Karolina Lawitz Member of the Board of Directors
NilsOlof Bjork Director
Yvonne Martensson Director
Check also Trending Equities. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Search macroaxis.com